Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 117,000 | 54,000 | 213,000 | 168,000 | 130,000 |
| Depreciation Amortization | 11,000 | 5,000 | 22,000 | 18,000 | 12,000 |
| Accounts receivable | 3,000 | 6,000 | -25,000 | 3,000 | 9,000 |
| Accounts payable and accrued liabilities | -29,000 | -75,000 | 201,000 | 30,000 | 6,000 |
| Other Working Capital | -134,000 | -115,000 | 173,000 | 30,000 | 19,000 |
| Other Operating Activity | -16,000 | 50,000 | -231,000 | -63,000 | -16,000 |
| Operating Cash Flow | $-48,000 | $-75,000 | $353,000 | $186,000 | $160,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -171,000 | -150,000 | N/A | N/A | N/A |
| PPE Investments | -2,000 | N/A | -4,000 | -2,000 | -1,000 |
| Sale Of Investment | 10,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | 1,000 | 1,000 | -10,000 | -10,000 | -29,000 |
| Other Investing Activity | 1,000 | 1,000 | -10,000 | -10,000 | -29,000 |
| Investing Cash Flow | $-162,000 | $-149,000 | $-14,000 | $-12,000 | $-30,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 250,000 | 250,000 | 250,000 |
| Debt Repayment | -1,000 | -1,000 | -236,000 | -236,000 | -235,000 |
| Common Stock Issued | N/A | 1,000 | 1,000 | N/A | N/A |
| Common Stock Repurchased | -29,000 | N/A | -101,000 | -34,000 | N/A |
| Other Financing Activity | -4,000 | -2,000 | -8,000 | -6,000 | -4,000 |
| Financing Cash Flow | $-34,000 | $-2,000 | $-94,000 | $-26,000 | $11,000 |
| Exchange Rate Effect | -1,000 | -2,000 | -1,000 | -1,000 | 1,000 |
| Beginning Cash Position | 1,102,000 | 1,102,000 | 858,000 | 858,000 | 858,000 |
| End Cash Position | 857,000 | 874,000 | 1,102,000 | 1,005,000 | 1,000,000 |
| Net Cash Flow | $-245,000 | $-228,000 | $244,000 | $147,000 | $142,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,000 | -75,000 | 353,000 | 186,000 | 160,000 |
| Capital Expenditure | -2,000 | N/A | -4,000 | -2,000 | -1,000 |
| Free Cash Flow | -50,000 | -75,000 | 349,000 | 184,000 | 159,000 |